New Releases from NCBI BookshelfBaricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal).Baricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal).By admin / February 12, 2025 Post Content